Rebalix
Logo AmundiAmundi · sheet of 10 September 2026
ETF sheet · official issuer and register data

Amundi Stoxx Europe 50 UCITS ETF Acc

C5E · FR0010790980 · EUR · domicile France
Equity · EuropeSFDR art. 6
Index tracked: STOXX Europe 50 Net Return EUR
TER
0.15%+ trans. 0.00%
Fund size
509 m EUR
Tracking difference
+0.12%3-year avg
🇮🇹 tax rate
white list not published
Replication
Synthetic (swap)
Income
Mixed (acc. and/or dist.)
Launch 22 Sept 2009 · costs from the KID as of 2 Sept 2026 · 59 securities held · 9 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
By subscribing to Amundi Stoxx Europe 50 UCITS ETF (the "Fund"), you are investing in a passive management UCITS whose objective is to replicate, as accurately as possible, the performance of the STOXX Europe 50 index (the "Index"), regardless of its performance, positive or negative. The maximum tracking error objective between the growth of the net asset value of the Fund and that of the Index is indicated in the Fund's prospectus. The Index, net dividends reinvested (dividends net of tax paid by the shares in the Index are included in the Index…

Performance since series start (in euro) — base 100

10 Jul 20178 Sept 2026 · dividends reinvested where declared by the issuer
2018202020222024202623084225
High 230 (7 Aug 2026) · low 84 (16 Mar 2020) · last 225. Past performance is not indicative of future results.

Returns in euro

1 year+22.3%
3 years+48.5%
5 years+71.7%
10 yearsseries too young
Since series start+125.4%

Risk · 1 / 3 / 5 years

Volatility (ann.)12.63%12.62%13.65%
Max drawdown−9.46%−17.13%−17.13%
Sharpe1.440.840.68
Sortino2.261.180.95
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · C5E · FR00107909801
RebalixC5E · FR0010790980 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · declared by the issuer
YearFundIndexTD
2025+17.49%+17.35%+0.14%
2024+8.23%+8.15%+0.08%
2023+15.28%+15.13%+0.15%
2022−1.67%−1.80%+0.12%
2021+26.14%+26.05%+0.09%

Holdings

Synthetic replication: top positions of the substitute basket (swap collateral), not the fund’s exposure · 1 Sept 2026 · 59 securities · top-10 weight = 59.0%
Top holdingsWeight
APPLE INC9.3%
MICROSOFT CORP8.9%
NVIDIA CORP8.7%
ELI LILLY & CO7.1%
CONSOLIDATED EDISON INC4.5%
AMAZON.COM INC4.5%
ABBVIE INC4.3%
ORACLE CORP4.1%
CENTENE CORP4.0%
ELEVANCE HEALTH INC3.7%

Listing venues

ESMA register (FIRDS) and official exchange lists
AE50 · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
C5E · Euronext Paris
+ 23 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · www.amundietf.it/pdfDocuments/kid-priips/FR0010790980/ENG/NLD
Factsheet · www.amundietf.it/pdfDocuments/monthly-factsheet/FR0010790980/ENG/GBR/I
Prospectus · www.amundietf.it/pdfDocuments/prospectus/FR0010790980/ENG/GBR
The live sheet, always up to date
rebalix.com/en/etf/FR0010790980
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · C5E · FR00107909802